Annual EBITDA
$928.62M$46.64M-4.78%
Summary
- Current Value
- As of today, CRL annual EBITDA is $928.62M, down -4.78% on
- Historical Performance
- CRL annual EBITDA is up +6.99% over the past 3 years, and up +57.21% over the past 5 years
- All-Time High Comparison
- CRL annual EBITDA is currently -4.78% below its historical high of $975.26M set on
- 3-Year Low Comparison
- CRL annual EBITDA is at its 3-year low
- Sector Comparison
- CRL annual EBITDA is higher than 93.55% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $928.62M | -4.8% | +7.0% | +57.2% | +237.3% | |
| Quarterly EBITDA | $236.25M | -0.1% | +4.2% | +21.4% | +293.6% | |
| TTM EBITDA | $907.49M | -4.6% | -7.0% | +35.9% | +291.9% | |
| Price | $219.70 | +32.5% | -5.5% | -19.7% | +486.0% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $4.05B | -1.9% | +14.4% | +54.5% | +236.8% | |
| Annual EPS | $0.20 | -97.8% | -97.4% | -96.1% | -88.5% | |
| Annual EBIT | $566.88M | -14.3% | -5.9% | +44.4% | +211.8% | |
| Annual Net Income | $25.29M | -94.7% | -93.7% | -90.0% | -76.9% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $975.26M | -4.8% | |
| 5Y | $975.26M | -4.8% | |
| All | $975.26M | -4.8% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $928.62M | at low | |
| 5Y | $693.88M | N/A | +33.8% |
| All | $37.67M | +2365.1% |
EBITDA History
FAQ
What is the current annual EBITDA of CRL?
As of today, CRL annual EBITDA is $928.62M
What is 1-year change in CRL annual EBITDA?
CRL annual EBITDA is down -4.78% year-over-year
What is 3-year change in CRL annual EBITDA?
CRL annual EBITDA is up +6.99% over the past 3 years
How far is CRL annual EBITDA from its all-time high?
CRL annual EBITDA is currently -4.78% below its historical high of $975.26M set on December 31, 2023
How does CRL annual EBITDA rank versus sector peers?
CRL annual EBITDA is higher than 93.55% of companies in Healthcare sector
When is CRL next annual earnings release?
The next annual earnings release for CRL is on
Quarterly EBITDA
$236.25M$15.60M-6.19%
Summary
- Current Value
- As of today, CRL quarterly EBITDA is $236.25M, down -6.19% on
- Historical Performance
- CRL quarterly EBITDA is down -0.13% year-over-year, and up +4.22% over the past 3 years
- All-Time High Comparison
- CRL quarterly EBITDA is currently -10.92% below its historical high of $265.20M set on
- 3-Year Low Comparison
- CRL quarterly EBITDA is +17.82% above its 3-year low of $200.52M reached on
- Sector Comparison
- CRL quarterly EBITDA is higher than 92.50% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $236.25M | -6.2% | -0.1% | +4.2% | +21.4% | |
| Annual EBITDA | $928.62M | – | -4.8% | +7.0% | +57.2% | |
| TTM EBITDA | $907.49M | -0.0% | -4.6% | -7.0% | +35.9% | |
| Price | $219.70 | +25.6% | +32.5% | -5.5% | -19.7% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $1.00B | -2.6% | -0.5% | +1.6% | +35.2% | |
| Quarterly EPS | $1.10 | +3.8% | -17.3% | -41.5% | -45.8% | |
| Quarterly EBIT | $151.08M | +14.2% | +1.8% | -0.7% | +11.9% | |
| Quarterly Net Income | $55.56M | +5.4% | -21.0% | -43.1% | -45.9% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $251.84M | -6.2% | |
| 3Y | $255.69M | -7.6% | |
| 5Y | $265.20M | -10.9% | |
| All | $265.20M | -10.9% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $200.52M | N/A | +17.8% |
| 3Y | $200.52M | +17.8% | |
| 5Y | $194.44M | N/A | +21.5% |
| All | $18.26M | +1193.8% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of CRL?
As of today, CRL quarterly EBITDA is $236.25M
What is CRL quarterly EBITDA most recent change?
CRL quarterly EBITDA was down -6.19% on September 27, 2025
What is 1-year change in CRL quarterly EBITDA?
CRL quarterly EBITDA is down -0.13% year-over-year
How far is CRL quarterly EBITDA from its all-time high?
CRL quarterly EBITDA is currently -10.92% below its historical high of $265.20M set on June 25, 2022
How does CRL quarterly EBITDA rank versus sector peers?
CRL quarterly EBITDA is higher than 92.50% of companies in Healthcare sector
When is CRL next earnings release?
The next earnings release for CRL is on
TTM EBITDA
$907.49M$303.00K-0.03%
Summary
- Current Value
- As of today, CRL TTM EBITDA is $907.49M, down -0.03% on
- Historical Performance
- CRL TTM EBITDA is down -4.62% year-over-year, and down -7.05% over the past 3 years
- All-Time High Comparison
- CRL TTM EBITDA is currently -7.69% below its historical high of $983.08M set on
- 3-Year Low Comparison
- CRL TTM EBITDA is at its 3-year low
- Sector Comparison
- CRL TTM EBITDA is higher than 92.68% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $907.49M | -0.0% | -4.6% | -7.0% | +35.9% | |
| Annual EBITDA | $928.62M | – | -4.8% | +7.0% | +57.2% | |
| Quarterly EBITDA | $236.25M | -6.2% | -0.1% | +4.2% | +21.4% | |
| Price | $219.70 | +25.6% | +32.5% | -5.5% | -19.7% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $4.02B | -0.1% | -0.9% | +6.4% | +42.5% | |
| TTM EPS | -$1.56 | -17.4% | -119.2% | -118.3% | -125.9% | |
| TTM EBIT | $480.35M | +0.6% | -21.4% | -29.6% | +8.6% | |
| TTM Net Income | -$79.62M | -22.7% | -118.6% | -118.0% | -126.4% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $921.09M | N/A | -1.5% |
| 3Y | $977.13M | -7.1% | |
| 5Y | $983.08M | -7.7% | |
| All | $983.08M | -7.7% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $907.49M | at low | |
| 3Y | $907.49M | at low | |
| 5Y | $691.88M | N/A | +31.2% |
| All | $20.99M | +4223.2% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of CRL?
As of today, CRL TTM EBITDA is $907.49M
What is CRL TTM EBITDA most recent change?
CRL TTM EBITDA was down -0.03% on September 27, 2025
What is 1-year change in CRL TTM EBITDA?
CRL TTM EBITDA is down -4.62% year-over-year
How far is CRL TTM EBITDA from its all-time high?
CRL TTM EBITDA is currently -7.69% below its historical high of $983.08M set on June 25, 2022
How does CRL TTM EBITDA rank versus sector peers?
CRL TTM EBITDA is higher than 92.68% of companies in Healthcare sector
When is CRL next earnings release?
The next earnings release for CRL is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- CRL Official Website www.criver.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1100682/000110068225000043/0001100682-25-000043-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1100682/000110068225000011/0001100682-25-000011-index.htm
- CRL Profile on Yahoo Finance finance.yahoo.com/quote/CRL
- CRL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/crl